Commentary: Frailty and cancer.

of Twin Registries (INTR): building a platform for international collaboration. Twin Res Hum Genet 2014;17:574–77. 3. McRae AF, Powell JE, Henders AK et al. Contribution of genetic variation to transgenerational inheritance of DNA methylation. Genome Biol 2014;15:R73. 4. Hopper JL. Disease-specific prospective family study cohorts enriched for familial risk. Epidemiol Perspect Innov 2011;8:2. 5. Aalen OO. Modelling the influence of risk factors on familial aggregation of disease. Biometrics 1991;47:933–45. 6. Dowty JG, Win AK, Buchanan DD et al. Cancer risks for MLH1 and MSH2 mutation carriers. Hum Mutat 2013;34: 490–97. 7. Win AK, Hopper JL, Buchanan DD et al. Are the common genetic variants associated with colorectal cancer risk for DNA mismatch repair gene mutation carriers? Eur J Cancer 2013;49:1578–87. 8. Tomasetti C, Vogelstein B. Variation in cancer risk among tissues can be explained by the number of cell divisions. Science 2015;347:78–81. 9. Mathews JD, Forsythe AV, Brady Z et al. Cancer risk in 680,000 people exposed to computed tomography scans in childhood or adolescence: data linkage study of 11 million Australians. BMJ 2013;346:f2360. 10. Pearce DC, Pallaghy PK, McCaw JM, McVernon J, Mathews JD. Understanding mortality in the 1918-1919 influenza pandemic in England and Wales. Influenza Other Respir Viruses 2011;5:89–98.